dc.creatorCosta, Federico
dc.creatorHagan, José E
dc.creatorCalcagno, Juan
dc.creatorKane, Michael
dc.creatorTorgerson, Paul
dc.creatorMartinez-Silveira, Martha Silvia
dc.creatorStein, Claudia
dc.creatorAbela-Ridder, Bernadette
dc.creatorKo, Albert Icksang
dc.date2015-10-07T19:40:49Z
dc.date2015-10-07T19:40:49Z
dc.date2015
dc.date.accessioned2023-09-26T20:35:19Z
dc.date.available2023-09-26T20:35:19Z
dc.identifierCOSTA, F. et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Neglected Tropical Diseases, v. 9, n. 9, p. 1-19, 2015.
dc.identifier1935-2735
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/11922
dc.identifier10.1371/journal.pntd.0003898
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8860114
dc.descriptionBackground Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis is a life-threatening disease and recognized as an important cause of pulmonary haemorrhage syndrome, the lack of global estimates for morbidity and mortality has contributed to its neglected disease status. Methodology/Principal Findings We conducted a systematic review of published morbidity and mortality studies and databases to extract information on disease incidence and case fatality ratios. Linear regression and Monte Carlo modelling were used to obtain age and gender-adjusted estimates of disease morbidity for countries and Global Burden of Disease (GBD) and WHO regions. We estimated mortality using models that incorporated age and gender-adjusted disease morbidity and case fatality ratios. The review identified 80 studies on disease incidence from 34 countries that met quality criteria. In certain regions, such as Africa, few quality assured studies were identified. The regression model, which incorporated country-specific variables of population structure, life expectancy at birth, distance from the equator, tropical island, and urbanization, accounted for a significant proportion (R2 = 0.60) of the variation in observed disease incidence. We estimate that there were annually 1.03 million cases (95% CI 434,000–1,750,000) and 58,900 deaths (95% CI 23,800–95,900) due to leptospirosis worldwide. A large proportion of cases (48%, 95% CI 40–61%) and deaths (42%, 95% CI 34–53%) were estimated to occur in adult males with age of 20–49 years. Highest estimates of disease morbidity and mortality were observed in GBD regions of South and Southeast Asia, Oceania, Caribbean, Andean, Central, and Tropical Latin America, and East Sub-Saharan Africa. Conclusions/Significance Leptospirosis is among the leading zoonotic causes of morbidity worldwide and accounts for numbers of deaths, which approach or exceed those for other causes of haemorrhagic fever. Highest morbidity and mortality were estimated to occur in resource-poor countries, which include regions where the burden of leptospirosis has been underappreciated
dc.formatapplication/pdf
dc.languageeng
dc.publisherPublic Library of Science
dc.rightsopen access
dc.subjectLeptospirose
dc.subjectMortalidade
dc.subjectMorbidade
dc.subjectEpidemiologia
dc.subjectLeptospirosis
dc.subjectMorbidity
dc.subjectMortality
dc.subjectEpidemiology
dc.subjectLeptospirose
dc.subjectVigilância da População
dc.titleGlobal morbidity and mortality of leptospirosis: a systematic review
dc.typeArticle


Este ítem pertenece a la siguiente institución